Three IP-related laws and policies have been released for public comment in the past week, at two different stages in the legislative process. The first and perhaps most significant is the revisions […]
Three Laws/Policies Up For Public Comment
Update on Research on Technology Protectionism and the Chinese Patent System
Prof. Gaétan de Rassenfosse and Dr. Emilio Raiteri (both at EPFL, the Swiss Federal Institute of Technology in Lausanne, Switzerland) have recently offered interesting statistical evidence for preferential treatment of domestic applicants […]
October Offerings on Chinese IP
Here are some upcoming programs that involve China in North American in October: October 11-12, 2017, I will be speaking on a China IP Panel at the ABA IP West conference in […]
USTR Announces Several Vacancies
USTR has posted the position of Assistant U.S. Trade Representative for China on the federal jobs website. The position closes August 4, 2017. Among the qualifications: 1. Demonstrated knowledge and experience in […]
Forthcoming Webinar on Developments in SEP Prosecution and Injunctive Relief in China
The Federal Circuit Bar Association and USPTO announced on July 17, 2017 that they are hosting a webinar on the latest research and developments in standards essential patents (SEPs) in China on […]
On Being an IP Trailblazer
I was named an IP Trailblazer by the National Law Journal for 2017. Here’s the link to this recognition by my peers in the US legal community. Thank you for your continual […]
Upcoming USPTO China Road Shows in Detroit and Grand Rapids
USPTO will be conducting two more of its China Road Shows July 10 and 12, 2017 in Detroit and Grand Rapids, Michigan. Invited VIP guests in Detroit include the Mayor of Detroit […]
Upcoming PTO Program on Sports Broadcasting
USPTO and China’s National Copyright Administration are co-sponsoring a program on IP (copyright) protection for sports broadcasts, an issue that has been under discussion at least since the Beijing Olympics (2008). Here […]
Vringo’s Litigation with ZTE: The Continuing Saga…
Vringo’s NDA dispute with ZTE has been previously noted in this blog. The case in the Southern District of New York involved violation of a Non-Disclosure Agreement by alleging revealing confidential materials […]
CFDA’s New Policies to Promote IP and Innovation in the Pharma Sector
As noted previously in this blog, the death of patent linkage which had been heralded by draft Drug Registration Rules appears to be premature. In fact, the China Food and Drug Administration […]
China IPR - Intellectual Property Developments in China 